Literature DB >> 20627726

Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS).

Joerg Heil1, Simone Holl, Michael Golatta, Geraldine Rauch, Joachim Rom, Frederik Marmé, Gerhard Gebauer, Christof Sohn.   

Abstract

This prospective cohort study was carried out to develop a German version of the Breast Cancer Treatment Outcome Scale (BCTOS) and to examine the relations of aesthetic and functional outcome after breast conserving surgery with quality of life (QoL). The study included 189 patients with one-sided, early stage breast cancer. A factor analysis indicated three internally consistent scales of the German BCTOS: Aesthetic Status, Functional Status and Breast Sensitivity Status. QoL was measured by the EORTC Quality of Life Questionnaire C30-BR23 (EORTC). All BCTOS scales were correlated with scales of the EORTC. Correlation magnitudes ranged from 0.24 to 0.67 (p < 0.001). A multiple regression analyses confirmed these results. The analysis of relevant covariates demonstrated that younger patients revealed poorer status on all BCTOS scales. Aesthetic and functional outcome seems to be closely related to quality of Life. The German BCTOS demonstrated to be a useful instrument.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20627726     DOI: 10.1016/j.breast.2010.05.004

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  8 in total

Review 1.  Evaluation of cross-cultural adaptation and measurement properties of breast cancer-specific quality-of-life questionnaires: a systematic review.

Authors:  Indiara Soares Oliveira; Lucíola da Cunha Menezes Costa; Felipe Ribeiro Cabral Fagundes; Cristina Maria Nunes Cabral
Journal:  Qual Life Res       Date:  2014-11-13       Impact factor: 4.147

Review 2.  Tumour-adapted Reduction Mammoplasty - a New (Old) Breast Conserving Strategy: Review.

Authors:  M Eichbaum; A Dietrich; J Reinhard; R Steinwasser; C Eichbaum
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-01       Impact factor: 2.915

3.  Patient reported cosmetic outcome after vacuum assisted excision of benign breast lesions: a cross-sectional study.

Authors:  Elles M F van de Voort; Taco M A L Klem; Gerson M Struik; Erwin Birnie; Renata H J A Sinke; Ali Ghandi
Journal:  Br J Radiol       Date:  2020-07-20       Impact factor: 3.039

4.  Litigation in breast surgery: unique insights from the English National Health Service experience.

Authors:  R L O'Connell; N Patani; J T Machin; T W R Briggs; T Irvine; F A MacNeill
Journal:  BJS Open       Date:  2021-05-07

5.  The potential role of three-dimensional surface imaging as a tool to evaluate aesthetic outcome after Breast Conserving Therapy (BCT).

Authors:  Rachel L O'Connell; Rosa Di Micco; Komel Khabra; Lisa Wolf; Nandita deSouza; Nicola Roche; Peter A Barry; Anna M Kirby; Jennifer E Rusby
Journal:  Breast Cancer Res Treat       Date:  2017-04-26       Impact factor: 4.872

6.  Validation of the Vectra XT three-dimensional imaging system for measuring breast volume and symmetry following oncological reconstruction.

Authors:  Rachel L O'Connell; Komel Khabra; Jeffrey C Bamber; Nandita deSouza; Farid Meybodi; Peter A Barry; Jennifer E Rusby
Journal:  Breast Cancer Res Treat       Date:  2018-06-05       Impact factor: 4.872

Review 7.  Patient-Reported Outcome Measures of Breast Cancer Surgery: Evidence Review and Tool Adaptation.

Authors:  Sima Marzban; Samin Shokravi; Sadegh Abaei; Payam Fattahi; Maryam Karami; Faezeh Tajari
Journal:  Cureus       Date:  2022-08-08

8.  Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?

Authors:  Benedikt Schaefgen; Annika Funk; H-P Sinn; Thomas Bruckner; Christina Gomez; Aba Harcos; Anne Stieber; Annabelle Haller; Juliane Nees; Riku Togawa; André Pfob; André Hennigs; Johanna Hederer; Fabian Riedel; Sarah Fastner; Christof Sohn; Jörg Heil; Michael Golatta
Journal:  Breast Cancer Res Treat       Date:  2021-12-08       Impact factor: 4.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.